287 related articles for article (PubMed ID: 26309163)
1. Extramural depth of rectal cancer tumor invasion at thin-section MRI: predicting treatment response to neoadjuvant chemoradiation.
Tong T; Sun Y; Cai S; Zhang Z; Gu Y
Oncotarget; 2015 Oct; 6(30):30277-86. PubMed ID: 26309163
[TBL] [Abstract][Full Text] [Related]
2. T3 subclassification using the EMD/mesorectum ratio predicts neoadjuvant chemoradiation outcome in T3 rectal cancer patients.
Shen L; Sun Y; Zhang H; Zhang J; Deng W; Wang Y; Yao Y; Yang L; Zhu J; Tong T; Liang L; Zhang Z
Br J Radiol; 2018 Jan; 91(1081):20170617. PubMed ID: 29072488
[TBL] [Abstract][Full Text] [Related]
3. Extramural depth of tumor invasion at thin-section MR in rectal cancer: associating with prognostic factors and ADC value.
Tong T; Yao Z; Xu L; Cai S; Bi R; Xin C; Gu Y; Peng W
J Magn Reson Imaging; 2014 Sep; 40(3):738-44. PubMed ID: 24307597
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemotherapy evaluation by MRI volumetry in rectal cancer followed by chemoradiation and total mesorectal excision: Initial experience.
Nougaret S; Fujii S; Addley HC; Bibeau F; Pandey H; Mikhael H; Reinhold C; Azria D; Rouanet P; Gallix B
J Magn Reson Imaging; 2013 Sep; 38(3):726-32. PubMed ID: 23152299
[TBL] [Abstract][Full Text] [Related]
5. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
Yu SK; Tait D; Chau I; Brown G
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
[TBL] [Abstract][Full Text] [Related]
6. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer.
Bates DDB; Mazaheri Y; Lobaugh S; Golia Pernicka JS; Paroder V; Shia J; Zheng J; Capanu M; Petkovska I; Gollub MJ
Abdom Radiol (NY); 2019 Nov; 44(11):3701-3708. PubMed ID: 31154482
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted MRI and MR- volumetry--in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer.
Birlik B; Obuz F; Elibol FD; Celik AO; Sokmen S; Terzi C; Sagol O; Sarioglu S; Gorken I; Oztop I
Magn Reson Imaging; 2015 Feb; 33(2):201-12. PubMed ID: 25460330
[TBL] [Abstract][Full Text] [Related]
9. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
[TBL] [Abstract][Full Text] [Related]
10. Profiling of rectal cancers MRI in pathological complete remission states after neoadjuvant concurrent chemoradiation therapy.
Kim H; Kim HM; Koom WS; Kim NK; Kim MJ; Kim H; Hur H; Lim JS
Clin Radiol; 2016 Mar; 71(3):250-7. PubMed ID: 26747329
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation.
Chang GJ; You YN; Park IJ; Kaur H; Hu CY; Rodriguez-Bigas MA; Skibber JM; Ernst RD
Dis Colon Rectum; 2012 Apr; 55(4):371-7. PubMed ID: 22426259
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
13. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation.
Oberholzer K; Menig M; Kreft A; Schneider A; Junginger T; Heintz A; Kreitner KF; Hötker AM; Hansen T; Düber C; Schmidberger H
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):842-8. PubMed ID: 21236593
[TBL] [Abstract][Full Text] [Related]
14. Diffusion-weighted magnetic resonance imaging in monitoring rectal cancer response to neoadjuvant chemoradiotherapy.
Barbaro B; Vitale R; Valentini V; Illuminati S; Vecchio FM; Rizzo G; Gambacorta MA; Coco C; Crucitti A; Persiani R; Sofo L; Bonomo L
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):594-9. PubMed ID: 22099033
[TBL] [Abstract][Full Text] [Related]
15. Semiquantitative Volumetry by Sequential PET/CT May Improve Prediction of Complete Response to Neoadjuvant Chemoradiation in Patients With Distal Rectal Cancer.
Dos Anjos DA; Perez RO; Habr-Gama A; São Julião GP; Vailati BB; Fernandez LM; de Sousa JB; Buchpiguel CA
Dis Colon Rectum; 2016 Sep; 59(9):805-12. PubMed ID: 27505108
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging accuracy in assessing tumour down-staging following chemoradiation in rectal cancer.
Suppiah A; Hunter IA; Cowley J; Garimella V; Cast J; Hartley JE; Monson JR
Colorectal Dis; 2009 Mar; 11(3):249-53. PubMed ID: 18513192
[TBL] [Abstract][Full Text] [Related]
17. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer.
Yeo SG; Kim DY; Kim TH; Jung KH; Hong YS; Chang HJ; Park JW; Lim SB; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):164-71. PubMed ID: 20004532
[TBL] [Abstract][Full Text] [Related]
18. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
[TBL] [Abstract][Full Text] [Related]
19. [Prediction of efficacy of neoadjuvant radiochemotherapy based on depth of invasion in T3 rectal cancer].
Shen L; Tong T; Zhang H; Sun Y; Zhu J; Cai G; Li G; Liang L; Cai X; Fan M; Huang J; Yang L; Sun W; Cai S; Zhang Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):551-5. PubMed ID: 24953360
[TBL] [Abstract][Full Text] [Related]
20. [The value of MRI with CUBE sequence in early evaluation of the efficacy of neoadjuvant therapy for locally advanced rectal cancer].
Wang X; Cao W; Liu D; Li F; Li W; Kang L; Deng Y; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):73-78. PubMed ID: 29354903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]